ClinicalTrials.govpublic full text
A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
hepatocellular carcinoma, hcc, liver cancer, child pugh a, hcc stage c, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981143
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.